Industry
Healthcare and life sciences with a focus on USA, Canada and India.
Customer success story
EWM greenfield implementation for a pharmaceutical organization
More transparent warehouse operations, inventory control and fulfillment in a regulated environment.
Helping your business enhance Customer Experience Ownership so it runs better, faster and cheaper, without the nonsense.
The Zircoo viewMake the next move
Make the next move
more usable.
More transparent warehouse operations, inventory control and fulfillment in a regulated environment. This narrative is organized for executive discovery and should be validated against the relevant business baseline before it is used as a quantified customer claim.
What we bringDesigned for the
Designed for the
real system.
Each capability is stronger when it is connected to the process, data and operating model around it.
The problem
The executive team needed to address close, profitability and management reporting depended on manual reconciliation and inconsistent master data. In this a regulated enterprise, the impact was visible through regulated supply, product integrity, clinical service, evidence and data quality.
The solution
The team aligned ledgers, cost objects, data ownership, close controls and executive reporting around a common finance operating model. The delivery was shaped for regulated supply, product integrity, clinical service, evidence and data quality and connected to the people who own the result.
The ROI result
Illustrative planning range: 15 to 25% shorter close effort and 5 to 9% lower reporting rework. Validate the range against the customer's baseline, scope and adoption plan.
The C-level lens
the COO, CIO and quality leadership receives a clearer line from the operating constraint to the investment decision, the accountable owner and the measurable value case.
Anonymized original storyFrom healthcare and life sciences problem
From healthcare and life sciences problem
to executive value.
More transparent warehouse operations, inventory control and fulfillment in a regulated environment.
Healthcare and life sciences
USA, Canada and India
What constrained the result
The executive team needed to address close, profitability and management reporting depended on manual reconciliation and inconsistent master data. In this a regulated enterprise, the impact was visible through regulated supply, product integrity, clinical service, evidence and data quality.
What changed in the system
The team aligned ledgers, cost objects, data ownership, close controls and executive reporting around a common finance operating model. The delivery was shaped for regulated supply, product integrity, clinical service, evidence and data quality and connected to the people who own the result.
Planning-level business case
Illustrative planning range: 15 to 25% shorter close effort and 5 to 9% lower reporting rework. Validate the range against the customer's baseline, scope and adoption plan.
Why the decision matters
the COO, CIO and quality leadership receives a clearer line from the operating constraint to the investment decision, the accountable owner and the measurable value case.
Use with careThis record preserves an original customer-story pattern while withholding customer names. Confirm current facts and quantified outcomes before external publication.
What changesOutcomes that
Outcomes that
hold up.
✓Clearer regulated supply, product integrity, clinical service, evidence and data quality visibility
✓Less manual coordination and avoidable exception work
✓Faster, better customer-service decisions
✓A foundation for continuous improvement
Keep exploringStart with the